In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Labeling Rule Will Require Rx Warnings To Appear At Beginning Of DTC Ads

This article was originally published in The Pink Sheet Daily

Executive Summary

The proposed physician labeling rule will by published by the end of November, FDA Acting Commissioner Crawford says. The rule is designed to provide more useful information to physicians and patients.

You may also be interested in...



Rx Labeling Final Rule Largely In Line With Draft Version

New labeling format will apply initially to recently approved drugs and products receiving approval for new uses, agency says.

Rx Labeling Final Rule Largely In Line With Draft Version

New labeling format will apply initially to recently approved drugs and products receiving approval for new uses, agency says.

FDA Physician Labeling Rule Withdrawn From OMB

Final rule has drawn opposition from industry, especially the addition of a "highlights" section. FDA is proposing staggered implementation to lower the costs of the labeling redesign. Rule would also affect DTC ads. Office of Management & Budget received the reg in January.

Related Content

Topics

UsernamePublicRestriction

Register

PS058130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel